IP Library Granted Patent US 9,693,873
Granted Patent B1
US 9,693,873 · App. 13/594,835 · Granted Jul 4, 2017

In vitro production of bone-like material

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,693,873
App. No.
13/594,835
Granted
Jul 4, 2017
Kind
B1
Abstract

Embodiments of the invention is directed to methods of forming a bone-like material, by placing a matrix into a culture container, adding cells to the matrix, placing the tissue-cell construct into the culturing environment and incubating the construct under appropriate conditions for the time required to produce an amount of bone-like material of sufficient volume to be harvested for further processing. Other embodiments of the invention are directed to the use of the bone-like material formed by methods of the invention in implantation procedures.

Claims (25)

1. A method of forming a bone-like material, comprising:

placing a matrix comprising calcium phosphate into a culture container;

adding mesenchymal stem cells to the matrix;

placing the matrix-cell construct into a culturing environment and incubating the construct under appropriate conditions for a time required to produce an amount of bone-like material of sufficient volume to be harvested for further processing.

2. The method of claim 1 , further comprising de-cellularizing the bone-like material using freeze thaw cycling or washing with detergents and solvents.

3. The method of claim 2 , further comprising forming the de-cellularized bone-like material into an implant.

4. The method of claim 3 , wherein the implant is a spinal fusion implant.

5. The method of claim 1 , wherein the matrix is tri-calcium phosphate, hydroxyapatite, demineralized bone matrix, collagen or polymers.

6. The method of claim 1 , wherein the calcium phosphate comprises allogenic bone fragments.

7. The method of claim 1 , wherein the calcium phosphate comprises one or more of hydroxyapatite, tricalcium phosphate, and carbonate apatite.

8. The method of claim 1 , wherein the matrix further comprises an orthopedic protein that comprises glycosaminoglycans or aggrecan.

9. A composition comprising:

an implant and bone-like material, wherein the bone-like material is bound to the implant and has the ability to bind to a component of an extracellular matrix of a biological tissue, whereby the implant and the biological tissue become attached upon introduction of the composition to biological tissue; and

wherein the bone-like material is formed by placing a matrix comprising calcium phosphate into a culture container, adding mesenchymal stem cells to the matrix, placing the tissue-cell construct into the culturing environment and incubating the construct under appropriate conditions for a time required to produce an amount of bone-like material.

10. The composition of claim 9 , wherein the bone-like material is formed in vitro.

11. The composition of claim 9 , wherein the implant is porous.

12. The composition of claim 9 , wherein the implant allows for migration of the mesenchymal stem cells into the implant.

13. The composition of claim 9 , wherein the implant comprises hydroxyapatite, tricalcium phosphate, fibrin or fibrinogen.

14. The composition of claim 9 , further comprising a growth factor.

15. A method of using the composition of claim 9 for treatment, repair or replacement of musculoskeletal tissue, by implantation of the composition into a subject in need thereof.

16. The method of claim 15 , wherein a subject receiving treatment is a mammal.

17. The method of claim 16 , wherein the mammal is a human.

18. The composition of claim 9 , wherein the calcium phosphate comprises allogenic bone fragments.

19. The composition of claim 9 , wherein the calcium phosphate comprises one or more of hydroxyapatite, tricalcium phosphate, and carbonate apatite.

20. The composition of claim 9 , wherein the matrix further comprises an orthopedic protein that comprises glycosaminoglycans or aggrecan.

Assignments (7)
RELEASE OF SECURITY INTEREST Recorded Apr 10, 2019
From: AMERICAN BANK
To: SPINESMITH HOLIDNGS, LLC
Reel/Frame 048853/0105 →
RELEASE OF SECURITY INTEREST Recorded Apr 10, 2019
From: SILICON VALLEY BANK
To: SPINESMITH HOLDINGS, LLC
Reel/Frame 048853/0183 →
SECURITY INTEREST Recorded Apr 9, 2019
From: SPINESMITH HOLDINGS, LLC
To: BLUEARC MEZZANINE PARTNERS I, LP
Reel/Frame 048839/0655 →
SECURITY INTEREST Recorded Dec 14, 2017
From: SPINESMITH HOLDINGS, LLC
To: AMERICAN BANK, N.A.
Reel/Frame 044882/0096 →
SECURITY INTEREST Recorded Mar 22, 2017
From: SPINESMITH HOLDINGS, LLC
To: BLUEARC MEZZANINE PARTNERS I, L.P.
Reel/Frame 042071/0370 →
SECURITY INTEREST Recorded Feb 18, 2015
From: SPINESMITH HOLDINGS, LLC
To: SILICON VALLEY BANK
Reel/Frame 035014/0066 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 27, 2012
From: SAND, THEODORE, MR.; MURPHY, MATTHEW, MR.; DUNWORTH, KEVIN, MR.
To: SPINESMITH PARTNERS, L.P.
Reel/Frame 028853/0278 →